Search Results - "Sarlós, Patrícia"

Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis by Solymár, Margit, Ivic, Ivan, Pótó, László, Hegyi, Péter, Garami, András, Hartmann, Petra, Pétervári, Erika, Czopf, László, Hussain, Alizadeh, Gyöngyi, Zoltán, Sarlós, Patrícia, Simon, Mária, Mátrai, Péter, Bérczi, Bálint, Balaskó, Márta

“…Metformin is the first-choice drug for patients with Type 2 diabetes, and this therapy is characterized by being weight neutral. However, in the elderly an…”
Get full text

Computed Tomography Severity Index vs. Other Indices in the Prediction of Severity and Mortality in Acute Pancreatitis: A Predictive Accuracy Meta-analysis by Mikó, Alexandra, Vigh, Éva, Mátrai, Péter, Soós, Alexandra, Garami, András, Balaskó, Márta, Czakó, László, Mosdósi, Bernadett, Sarlós, Patrícia, Erőss, Bálint, Tenk, Judit, Rostás, Ildikó, Hegyi, Péter

“…The management of the moderate and severe forms of acute pancreatitis (AP) with necrosis and multiorgan failure remains a challenge. To predict the severity…”
Get full text

Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta‐analysis and systematic review by Erőss, Bálint, Farkas, Nelli, Vincze, Áron, Tinusz, Benedek, Szapáry, László, Garami, András, Balaskó, Márta, Sarlós, Patrícia, Czopf, László, Alizadeh, Hussain, Rakonczay, Zoltán, Habon, Tamás, Hegyi, Péter

“…Introduction The prevalence of Helicobacter pylori infection (HPI) has been decreasing in developed countries, with an increasing prevalence of Barrett's…”
Get full text

Meta-Analysis of the Long Term Success Rate of Different Interventions in Benign Biliary Strictures by Huszár, Orsolya, Kokas, Bálint, Mátrai, Péter, Hegyi, Péter, Pétervári, Erika, Vincze, Áron, Pár, Gabriella, Sarlós, Patrícia, Bajor, Judit, Czimmer, József, Mosztbacher, Dóra, Márta, Katalin, Zsiborás, Csaba, Varjú, Péter, Szücs, Ákos

“…Benign biliary stricture is a rare condition and the majority of the cases are caused by operative trauma or chronic inflammation based on various etiology…”
Get full text

Classical celiac disease is more frequent with a double dose of HLA-DQB102: A systematic review with meta-analysis by Bajor, Judit, Szakács, Zsolt, Farkas, Nelli, Hegyi, Péter, Illés, Anita, Solymár, Margit, Pétervári, Erika, Balaskó, Márta, Pár, Gabriella, Sarlós, Patrícia, Szűcs, Ákos, Czimmer, József, Szemes, Kata, Huszár, Orsolya, Varjú, Péter, Vincze, Áron

“…Experimental data suggest that the HLA-DQ2 gene dose has a strong quantitative effect on clinical outcomes and severity of celiac disease (CD). We aimed to…”
Get full text

Letter: suicide risk among adult inflammatory bowel disease patients by Sánta, Anett, Szántó, Kata Judit, Sarlós, Patrícia, Miheller, Pál, Farkas, Klaudia, Molnár, Tamás

“…LINKED CONTENT This article is linked to Malham et al papers. To view these articles, visit https://doi.org/10.1111/apt.15258 and…”
Get full text

Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis by Kiss, Szabolcs, Németh, Dávid, Hegyi, Péter, Földi, Mária, Szakács, Zsolt, Erőss, Bálint, Tinusz, Benedek, Hegyi, Péter Jenő, Sarlós, Patrícia, Alizadeh, Hussain

“…The goal of treatment in ulcerative colitis (UC) is to induce and maintain remission. The addition of granulocyte and monocyte apheresis (GMA) to conventional…”
Get full text

Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis by Szakács, Zsolt, Erőss, Bálint, Soós, Alexandra, Mátrai, Péter, Szabó, Imre, Pétervári, Erika, Bajor, Judit, Farkas, Nelli, Hegyi, Péter, Illés, Anita, Solymár, Margit, Balaskó, Márta, Sarlós, Patrícia, Szűcs, Ákos, Czimmer, József, Vincze, Áron, Pár, Gabriella

“…The Baveno VI Consensus Workshop defined criteria (liver stiffness measured by transient elastography <20 kPa and platelet count >150 × 10 cells/L) to identify…”
Get full text

Mucoprotective drugs can prevent and treat nonsteroidal anti-inflammatory drug-induced small bowel enteropathy: a systematic review and meta-analysis of randomized controlled trials by Teutsch, Brigitta, Boros, Eszter, Váncsa, Szilárd, Váradi, Alex, Frim, Levente, Kiss, Szabolcs, Dembrovszky, Fanni, Helyes, Zsuzsanna, Patrícia, Sarlós, Péter, Hegyi, Erőss, Bálint

“…Background: Small bowel enteropathy (SBE) is a complication of nonsteroidal anti-inflammatory drug (NSAID) therapy occurring in 71% of NSAID users. We aimed to…”
Get full text

Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis by Benke, Márton, Farkas, Nelli, Hegyi, Péter, Tinusz, Benedek, Sarlós, Patrícia, Erőss, Bálint, Szemes, Kata, Vörhendi, Nóra, Szakács, Zsolt, Szücs, Ákos

“…Pancreatic ductal adenocarcinoma has one of the worst prognosis of all malignancies. This investigated the relationship between the preoperative serum…”
Get full text

Aging and Comorbidities in Acute Pancreatitis I: A Meta-Analysis and Systematic Review Based on 194,702 Patients by Márta, Katalin, Lazarescu, Alina-Marilena, Farkas, Nelli, Mátrai, Péter, Cazacu, Irina, Ottóffy, Máté, Habon, Tamás, Erőss, Bálint, Vincze, Àron, Veres, Gábor, Czakó, László, Sarlós, Patrícia, Rakonczay, Zoltán, Hegyi, Péter

“…Acute pancreatitis (AP) is one of the most common cause of hospitalization among gastrointestinal diseases worldwide. Although most of the cases are mild,…”
Get full text

Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD) by Erős, Adrienn, Dohos, Dóra, Veres, Gábor, Tárnok, András, Vincze, Áron, Tészás, Alexandra, Zádori, Noémi, Gede, Noémi, Hegyi, Péter, Sarlós, Patrícia

“…IntroductionInflammatory bowel diseases (IBD) are among the most common chronic illnesses diagnosed in childhood. Transition from paediatric to adult care is a…”
Get full text

Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases by Bacsur, Péter, Resál, Tamás, Sarlós, Patrícia, Iliás, Ákos, Dalma Sümegi, Liza, Kata, Diána, Dávid, Anett, Farkas, Bernadett, Ivány, Emese, Bálint, Anita, Bősze, Zsófia, Fábián, Anna, Bor, Renáta, Szepes, Zoltán, Afif, Waqqas, Bessissow, Talat, Farkas, Klaudia, Lakatos, Péter L, Molnár, Tamás

“…The usability of subcutaneous vedolizumab (s.c. VDZ) treatment in inflammatory bowel diseases (IBD; ulcerative colitis (UC), Crohn's disease (CD)) has been…”
Get full text

Aging and Comorbidities in Acute Pancreatitis II.: A Cohort-Analysis of 1203 Prospectively Collected Cases by Szakács, Zsolt, Gede, Noémi, Pécsi, Dániel, Izbéki, Ferenc, Papp, Mária, Kovács, György, Fehér, Eszter, Dobszai, Dalma, Kui, Balázs, Márta, Katalin, Kónya, Klára, Szabó, Imre, Török, Imola, Gajdán, László, Takács, Tamás, Sarlós, Patrícia, Gódi, Szilárd, Varga, Márta, Hamvas, József, Vincze, Áron, Szentesi, Andrea, Párniczky, Andrea, Hegyi, Péter

“…Our meta-analysis indicated that aging influences the outcomes of acute pancreatitis (AP), however, a potential role for comorbidities was implicated, as well…”
Get full text

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study by Resál, Tamás, Bacsur, Péter, Keresztes, Csilla, Bálint, Anita, Bor, Renáta, Fábián, Anna, Farkas, Bernadett, Katsanos, Kostas, Michalopoylos, George, Ribaldone, Davide Giuseppe, Attauabi, Mohamed, Zhao, Mirabella, Barak, Hadar Amir, Yanai, Henit, Bezzio, Cristina, Rispo, Antonio, Castiglione, Fabiana, Bar-Gil Shitrit, Ariella, Pugliese, Daniela, Armuzzi, Alessandro, Savarino, Edoardo Vincenzo, Kolar, Martin, Lukáš, Milan, Chashkova, Elena, Filip, Rafał, Rozieres, Aurore, Nancey, Stéphane, Krznarić, Željko, Schäfer, Eszter, Szamosi, Tamás, Sarlós, Patrícia, Franko, Matej, Drobne, David, Knyazev, Oleg V, Kagramanova, Anna V, Limdi, Jimmy, Wetwittayakhlang, Panu, Lakatos, Peter L, Maharshak, Nitsan, Bannon, Lian, Nyári, Tibor, Szepes, Zoltán, Farkas, Klaudia, Molnár, Tamás

“…Tofacitinib (TFB) appears to be effective in the treatment of ulcerative colitis (UC); however, available real-world studies are limited by cohort size. TFB…”
Get full text

Elevated urinary orosomucoid excretion as a novel biomarker in Crohn’s disease by Szirmay, Balázs, Tárnok, András, Sarlós, Patrícia, Szigeti, Nóra, Ludány, Andrea, Kustán, Péter, Horváth‐Szalai, Zoltán, Miseta, Attila, Kőszegi, Tamás

“…Background Laboratory markers are essential tools in the follow‐up of patients with Crohn's disease (CD). Our aim was to investigate urinary concentrations of…”
Get full text

Accuracy of the Helicobacter pylori diagnostic tests in patients with peptic ulcer bleeding: a systematic review and network meta-analysis by Vörhendi, Nóra, Soós, Alexandra, Anne Engh, Marie, Tinusz, Benedek, Szakács, Zsolt, Pécsi, Dániel, Mikó, Alexandra, Sarlós, Patrícia, Hegyi, Péter, Eröss, Bálint

“…Introduction: Some studies suggest that the accuracy of Helicobacter pylori diagnostic tests is decreased in peptic ulcer bleeding (PUB). We aimed to assess…”
Get full text

Gender difference in the effects of interleukin-6 on grip strength - a systematic review and meta-analysis by Mikó, Alexandra, Pótó, László, Mátrai, Péter, Hegyi, Péter, Füredi, Nóra, Garami, András, Illés, Anita, Solymár, Margit, Vincze, Áron, Balaskó, Márta, Pár, Gabriella, Sarlós, Patrícia, Bajor, Judit, Tenk, Judit, Rostás, Ildikó, Pétervári, Erika

“…Aging sarcopenia characterized by low muscle mass with low muscle strength affects men and women differently. The contribution of interleukin-6 (IL-6) to…”
Get full text

Diabetes Mellitus Increases the Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy: Systematic Review and Meta-Analysis by Váncsa, Szilárd, Németh, Dávid, Hegyi, Péter, Szakács, Zsolt, Farkas, Ádám, Kiss, Szabolcs, Hegyi, Péter Jenő, Kanjo, Anna, Sarlós, Patrícia, Erőss, Bálint, Pár, Gabriella

“…Background: Hepatitis C virus (HCV)-infected patients treated with direct-acting antivirals (DAAs) are still at risk of developing hepatocellular carcinoma…”
Get full text

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study by Bacsur, Péter, Matuz, Mária, Resál, Tamás, Miheller, Pál, Szamosi, Tamás, Schäfer, Eszter, Sarlós, Patrícia, Iliás, Ákos, Szántó, Kata, Rutka, Mariann, Bálint, Anita, Milassin, Ágnes, Fábián, Anna, Bor, Renáta, Szepes, Zoltán, Molnár, Tamás, Farkas, Klaudia

“…Background: Treatment with antitumor necrosis factor alpha (anti-TNF-α) is safe and effective as first-line therapy; however, its efficacy is limited due to…”
Get full text